# FDA 483 - Mandeep S. Oberoi, M.D. - January 10, 2020

Source: https://www.globalkeysolutions.net/records/483/mandeep-s-oberoi-md/8b3bc0fa-0c5d-4def-a44a-bd7d8efaa1e3

> FDA 483 for Mandeep S. Oberoi, M.D. on January 10, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Mandeep S. Oberoi, M.D.
- Inspection Date: 2020-01-10
- Product Type: drugs
- Office Name: New Jersey District Office
- Summary: Mandeep S. Oberoi, M.D., a clinical investigator in Elizabeth, NJ, was cited for one observation during an FDA inspection from December 2019 to January 2020. The inspection revealed a failure to retain investigational records for a study subject for the required period following drug marketing application approval. This indicates a lapse in record-keeping practices.

## Related Officers

- [Regulatory Officer](https://www.globalkeysolutions.net/people/peter-r-lenahan/c695dac2-5447-434b-801e-f95e6acf05f1)

Company: https://www.globalkeysolutions.net/companies/mandeep-s-oberoi-md/4bac5b7b-c63f-4bf6-b135-46d1364e0704

Office: https://www.globalkeysolutions.net/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248